Amarin Looks to 2013 as Potential Blockbuster Year; January 7th Presentation in Focus (AMRN)

From Trading Tips
January 3, 2013 - 3:14pm

Despite rising 8% in 2012, by most accounts it was a very disappointing year for Amarin (AMRN) shareholders, according to a January 2 story in StreetInsider.com. After receiving FDA approval for Vascepa mid-year, and seeing its stock rise as much as 113%, AMRN shares hit the skids at the end of the year. Mainly, this [...]


Share this article »  

Continue reading this article »